The global adrenocorticotropic hormone receptor market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The adrenocorticotropic hormone receptor is a G-protein coupled receptor. This receptor plays a pivotal role in the regulation of glucocorticoid synthesis and secretion by cortisol which is produced from cholesterol through the adrenal gland. The binding of adrenocorticotropic hormone to its receptor stimulates adenylate cyclase, which results in increased levels of cAMP that promote steroidogenesis. The major factors attributed to the market growth includes the growing prevalence of hormonal disorders and the increasing geriatric population base. Increasing prevalence of hormonal disorders such as hypothyroidism and diabetes mellitus lead to increased demand for drugs that support to regulate these conditions. 

In 2018, about 30 million people in the US had diabetes, as per the IDF (International Diabetes Federation). Further, in 2019, the total adult population in the US with diabetes was 31.0 million while in Canada was 2.8 million. The US has the largest population of children and adolescents with type 1 diabetes (175,900). Moreover, there were around 189,000 mortalities due to diabetes in the US in 2019, which represents one of the highest numbers of mortalities around the globe. Adding to this, along with the various advantages such as improved compliance rate with treatment and high patient satisfaction, among others, biologics drugs will continue to remain dominant over small molecules in the future years.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Type

o By Application

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape:  Pfizer Inc., and Merck KGaA, among others. 

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Adrenocorticotropic Hormone Receptor Market Report by Segment

By Type

• AQB-565

• BIM-23B065

• Corticotropin

By Application

• Hormonal Disorder

• Musculoskeletal Disorder

• Crushing Disease

• Acromegaly

Global Adrenocorticotropic Hormone Receptor Market Report by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa